James Januzzi Jr MD(@JJheart_doc) 's Twitter Profileg
James Januzzi Jr MD

@JJheart_doc

Adolph Hutter Professor at Harvard and @MGHHeartHealth. Director of HF and Biomarker Trials @BaimInstitute. @RedSox team doc. Deputy Editor @JACCJournals.

ID:1053450823

linkhttp://www.massgeneral.org/doctors/doctor.aspx?id=17167&firstName=James&lastName=Januzzi&initial=Lou calendar_today01-01-2013 20:39:02

9,4K Tweets

16,5K Followers

2,5K Following

Cian McCarthy(@CianPMcCarthy) 's Twitter Profile Photo

Out today in JAMA, in this Viewpoint available with free access, Jason H. Wasfy, M.D., James Januzzi Jr MD, and I pose the question:

Is Myocardial Infarction Overdiagnosed?

jamanetwork.com/journals/jama/…

account_circle
Baim Institute(@BaimInstitute) 's Twitter Profile Photo

Study finds elevated NT-proBNP levels in T2 patients indicate worse and kidney outcomes, regardless of prior HF history. Higher risk with HF diagnosis.
Baim faculty James Januzzi Jr MD Javed Butler
doi.org/10.1016/j.card…

Study finds elevated NT-proBNP levels in T2 #Diabetes patients indicate worse #HeartFailure and kidney outcomes, regardless of prior HF history. Higher risk with HF diagnosis. #CardiovascularRisk #CANVAStrial Baim faculty @JJheart_doc @JavedButler1 doi.org/10.1016/j.card…
account_circle
xavier prida(@XavierPrida) 's Twitter Profile Photo

Almost too much cardiology genius for one place to contain. Admirers of what both James Januzzi Jr MD and AntonioAbbate have done in good works that translate to patients and nex gen cardiologists .

account_circle
Patricia Rodriguez-Lozano(@PRodriguezMD) 's Twitter Profile Photo

Thank you, Dr. James Januzzi Jr MD , for the enlightening talk on evolution of cardiac biomarker testing at cardiology grand rounds UVA Cardio
🌟Scalable omics approaches promise to unveil novel clinical biomarkers and therapeutic targets for diagnosis Christopher Kramer MD UVA Cardiology Fellowship

Thank you, Dr. @JJheart_doc , for the enlightening talk on evolution of cardiac biomarker testing at cardiology grand rounds @CardioUva 🌟Scalable omics approaches promise to unveil novel clinical biomarkers and therapeutic targets for diagnosis @ChrisKramerMD @UVACardsFellows
account_circle
Meagan Murphy Wasfy(@MeaganWasfy) 's Twitter Profile Photo

💛💙💛💙💛💙💛💙💛💙
An amazing day with the best race medical program Boston Marathon B.A.A. !

Congrats to all the 🏃🏻‍♀️ 🏃🏻‍♀️🏃🏻‍♀️🏃🏻‍♀️!

💛💙💛💙💛💙💛💙💛💙 An amazing day with the best race medical program @bostonmarathon @BAA ! Congrats to all the 🏃🏻‍♀️ 🏃🏻‍♀️🏃🏻‍♀️🏃🏻‍♀️!
account_circle
JACC Journals(@JACCJournals) 's Twitter Profile Photo

In patients irrespective of EF, the KCCQ-TSS shows rapid improvement within the initial treatment period following treatment. These findings are vital for treatment guidance and future study designs. bit.ly/3Q4A6uZ

In #HeartFailure patients irrespective of EF, the KCCQ-TSS shows rapid improvement within the initial treatment period following #canagliflozin treatment. These findings are vital for treatment guidance and future study designs. bit.ly/3Q4A6uZ #JACCHF #SGLT2i
account_circle
Jamal Rana, MD(@JamalRanaMD) 's Twitter Profile Photo

Saurabh S Dani, MD, MSc Jaideep Salim Virani Anandita Agarwala Kulkarni, MD FACC Romit Bhattacharya Dinesh Kalra, MD Aarti M Thakkar Sarju Ganatra, MD, FACC Time to disaggregate 'Asian' as one group in U.S. when it comes to cardiometabolic 🩷 risk & prevention. 'South Asians' higher risk for diabetes and we found 'Filipino Asians' higher prevalence of hypertension across lifespan! Our paper in AJPM Focus

ajpmfocus.org/article/S2773-…

@SaurabhSDani @jaideeppatelmd @virani_md @AAgarwalaMD @RomitB_MD @DineshKalra @aarti693 @SarjuGanatraMD Time to disaggregate 'Asian' as one group in U.S. when it comes to cardiometabolic 🩷 risk & prevention. 'South Asians' higher risk for diabetes and we found 'Filipino Asians' higher prevalence of hypertension across lifespan! Our paper in @AJPMFocus ajpmfocus.org/article/S2773-…
account_circle